Related Experiment Videos
[Phase I clinical trials in oncology: ethical issues]
1Unité d'Oncologie Médicale, Service de Médecine Interne, Hôpital Cochin, Paris, France. francois.goldwasser@cch.ap-hop-paris.fr
Therapie
|November 24, 2004
Summary
Phase I clinical trials in oncology optimize drug dosage and schedule based on toxicity. These trials offer cancer patients early access to novel therapies, balancing hope and anxiety in the doctor-patient relationship.
Area of Science:
- Oncology
- Clinical Pharmacology
- Cancer Therapeutics
Context:
- Phase I clinical trials are crucial for early-stage cancer research.
- Patients often lack alternative treatment options.
- Trials provide early access to investigational cancer drugs.
Purpose:
- Determine optimal drug dosage and administration schedule.
- Evaluate the safety and toxicity profile of new oncology drugs.
- Establish the maximum tolerated dose (MTD) for further studies.
Summary:
- Phase I trials focus on dose-finding and safety assessment in oncology.
- They enroll cancer patients with limited therapeutic alternatives.
- The study aims to optimize drug regimens based on observed toxicity.
Impact:
- Informs the design of subsequent Phase II and III trials.
- Facilitates the development of novel cancer treatments.
- Provides a pathway for patients seeking innovative therapies.